Onctura commences randomized Phase I/II study in non-small cell lung cancer First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have ...

Breakthrough promises ultra-high-resolution spectroscopy with wide variety of applications By Jed Thomas A new study ...

"Dry AMD is driven by a number of factors that contribute to the death of retinal cells, leading to irreversible vision loss," stated Mary Hamby, PhD, vice president of research. "Preclinical research ...

IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian cancer Data from Phase 2 OVATION 2 Study are encouraging, ...

Superbooth 25: Korg has been teasing an ‘acoustic synthesis’ product for a couple of years now. We first got wind of it at ...

Implementing advanced systems for receiving and decoding satellite signals is crucial for efficiently managing this deluge of information.

Karan Johar recently opened up about a deeply personal phase in his life, revealing that he took voice modulation classes for ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

Coherent optics equipment includes optical networking devices and equipment that help to promote 100G+ speed and aid in transmitting high volume of information by increasing the t ...

BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...